
The Zappasodi Lab studies immunosuppressive T cells in the response to cancer immunotherapy at @WeillCornell supported by @parkerici
New York, NY
Joined July 2020
- Tweets26
- Following276
- Followers443
- Likes74
Pinned Tweet
🔍#HIRING in #NYC! Are you excited about cancer #Immunotherapy? Interested in new mechanisms of T cell regulation? Want a career in translational science? Apply for opportunities in the @ZappasodiLab at @WeillCornell:
POSTDOC: https://teapawt.net/t.co/gYZWGXLpAS
TECH: https://teapawt.net/t.co/Kr0qERuenM
Zappasodi Lab retweeted
Glycolytic capacity instructs tumour vasculature and response to immunotherapy dlvr.it/TTHMrt
🧬 Preprint watch: tumour glycolytic capacity instructs tumour vasculature and shapes response to immunotherapy.
🙏 Thank you to @NatRevImmunol for highlighting our preprint!
nature.com/articles/s41577-0…
📄 Serganova, Colombo et al., bioRxiv
#JournalClub #ICB #TumorMetabolism
Deeply honored and grateful for being supported by the @CancerResearch Clinic & Laboratory Integration Program (CLIP) grant to advance our studies on "fragile" Tregs in anti-tumor immunity cancerresearch.org/cri-funde…
👩🔬 Science in action—tune in! 🎧
🎧 NEW PODCAST: Tumors hoard nutrients, starving immune cells – but researchers are flipping the script. In our latest episode of From Bench to Fireside, @RZappasodi of @WeillCornell & PICI’s @John_E_Connolly discuss how fueling T cells could change immunotherapy. Listen now: podcasts.apple.com/us/podcas…
Let's inspire the next generation of women in STEM! 💪#InternationalDayofWomenandGirlsinScience @RZappasodi @inna_privet32 @judygilmore09
Welcome to our family Giorgia Colombo @judygilmore09! We are so proud to have you join us as a postdoc supported by @AIRC_it: congratulations 🥳and looking forward to many more successes together!
Check out our new @trendscancer review on #Treg plasticity in #cancerimmunotherapy, led by @WCM_IMP student Jee Hye Kang at @WeillCornell authors.elsevier.com/a/1hbvF…
Zappasodi Lab retweeted
#TrendingWithImpact: On June 19, 2023, researchers Diwakar Davar & Roberta Zappasodi from @PittTweet & @Cornell published a new research perspective, entitled, “Targeting GITR in cancer immunotherapy – there is no perfect knowledge.”
#PressRelease: oncotarget.com/news/pr/targe…
Thanks for the wonderful visit @UCLA, where the sun is always up and the only storm is made of brain🧠so much fun brainstorming with Rob Prins, @ManishButte, Yvonne Chen, @PuigSaus, Tim O’Sullivan, Steven Bensinger, Lili Yang, @CampKatiee: it was an honor to speak at your #I3T!
8
793
Our Christmas song, written by
#ChatGPT
"I don't want a lot for Christmas
This is all I'm asking for
I just want to block CTLA-4
And make those tumors sore
I won't ask for much this Christmas
I won't even wish for snow
I'm just gonna keep on blocking
Until those tumors go"
#HIRINGNOW Tech position available in our group 👉https://teapawt.net/t.co/Kr0qERuMdk 🧑🔬👩🔬
🔍#HIRING in #NYC! Are you excited about cancer #Immunotherapy? Interested in new mechanisms of T cell regulation? Want a career in translational science? Apply for opportunities in the @ZappasodiLab at @WeillCornell:
POSTDOC: https://teapawt.net/t.co/gYZWGXLpAS
TECH: https://teapawt.net/t.co/Kr0qERuenM
The Parker Scholar award has supported research stars like @RZappasodi, who started as a scholar and is now a decorated assistant professor at @WeillCornell running her own lab. She is investigating immunosuppressive T cells. Learn more at parkerici.org/network/early-….
So proud to echo this! It has been an amazing journey with an incredibly talented team. When mathematicians meet immunologists amazing discoveries can happen 🙌@bengrbm @dfhoyosg @MartaLuksza @merghout
Our latest work is out today in @Nature with many great collaborators and supporters to thank, led by the amazing @dfhoyosg & @ZappasodiLab. I wanted to highlight some points for a project we have been working on for many years:
nature.com/articles/s41586-0…
Making progress with GITR agonists – many thanks to the patients that made this study possible tinyurl.com/4ue2xdt4. #immunotherapy #cancerresearch @CCR_AACR @diwakardavar @merghout @wolchokj @jasonlukemd
Our new review article is out @NatImmunol – revisiting 10 years of lessons learned with immune checkpoint blockade therapy in melanoma. Learned a lot and had much fun with @AlexHuang! nature.com/articles/s41590-0…
🔬Linking #epigenetics, #metabolism and the #immune microenvironment through #Bcell #lymphoma: check out our new review👉https://teapawt.net/t.co/YEFlkkphLN. Big thanks to the @LabMelnick for illuminating us on B-cell lymphoma biology and @inna_privet32 for leading this team effort🎉
Zappasodi Lab retweeted
Amazing #postdoc opportunity in the @ZappasodiLab at @WeillCornell studying T cell regulatory mechanisms and anti-tumor humoral immunity in the response to #cancer #immunotherapy
@parkerici @RZappasodi
#sciencejobs #CancerResearch #phdlife #immunology
gotbenchspace.com/job/postdo…
Deeply grateful to Dr. Larry Saltzman's Team and the @LLSusa for supporting my lab @WeillCornell with an incredibly generous grant to harness epigenetic reprogramming for improving B-cell lymphoma immunotherapy. #LLSTRP #cancerimmunotherapy #lymphoma
Another fascinating function of CTLA-4 blockade: it gets Tregs "sugar high" improving anti-tumor immunity. Just out in @nature! Thanks to the WolchokLab, BlasbergLab, KoutcherLab
@sloan_kettering, @DelgoffeLab, @HolabUnil for the fantastic collaboration. is.gd/RyuM8N













